Involving seldom-heard groups in a PPI process to inform the design of a proposed trial on the use of probiotics to prevent preterm birth: a case study by Rayment, J. et al.
              
City, University of London Institutional Repository
Citation: Rayment, J., Lanlehin, R., McCourt, C. & Husain, S. M. (2017). Involving 
seldom-heard groups in a PPI process to inform the design of a proposed trial on the use of 
probiotics to prevent preterm birth: a case study. Research Involvement and Engagement, 
3(1), 11.. doi: 10.1186/s40900-017-0061-3 
This is the published version of the paper. 
This version of the publication may differ from the final published 
version. 
Permanent repository link:  http://openaccess.city.ac.uk/18068/
Link to published version: http://dx.doi.org/10.1186/s40900-017-0061-3
Copyright and reuse: City Research Online aims to make research 
outputs of City, University of London available to a wider audience. 
Copyright and Moral Rights remain with the author(s) and/or copyright 
holders. URLs from City Research Online may be freely distributed and 
linked to.
City Research Online:            http://openaccess.city.ac.uk/            publications@city.ac.uk
City Research Online
RESEARCH ARTICLE Open Access
Involving seldom-heard groups in a
PPI process to inform the design of a
proposed trial on the use of probiotics
to prevent preterm birth: a case study
Juliet Rayment1* , Rosemary Lanlehin1, Christine McCourt1 and Shahid M. Husain2
* Correspondence:
juliet.rayment.1@city.ac.uk
1School of Health Sciences, City,
University of London, 1 Myddelton
Street, London EC1R 1UW, UK
Full list of author information is
available at the end of the article
Plain English summary
When designing clinical trials it is important to involve members of the public, who can
provide a view on what may encourage or prevent people participating and on what
matters to them. This is known as Public and Patient Involvement (PPI). People from
minority ethnic groups are often less likely to take part in clinical trials, but it is
important to ensure they are able to participate fully so that health research and its
findings are relevant to a wide population. We are preparing to conduct a randomised
controlled trial (RCT) to test whether taking probiotic capsules can play a role in
preventing preterm birth. Women from some minority ethnic groups, for example
women from West Africa, and those who are from low-income groups are more likely
to suffer preterm births. Preterm birth can lead to extra costs to health services and
psychosocial costs for families. In this article we describe how we engaged women in
discussion about the design of the planned trial, and how we aim to use our findings
to ensure the trial is workable and beneficial to women, as well as to further engage
service users in the future development of the trial. Four socially and ethnically diverse
groups of women in East London took part in discussions about the trial and
contributed their ideas and concerns. These discussions have helped to inform and
improve the design of a small practice or ‘pilot’ trial to test the recruitment in a ‘real life’
setting, as well as encourage further PPI involvement for the future full-scale trial.
Abstract
Background Patient and public involvement (PPI) is an important tool in approaching
research challenges. However, involvement of socially and ethnically diverse
populations remains limited and practitioners need effective methods of involving a
broad section of the population in planning and designing research.
Methods In preparation for the development of a pilot randomised controlled trial
(RCT) on the use of probiotics to prevent preterm birth, we conducted a public
consultation exercise in a socially disadvantaged and ethnically diverse community. The
consultation aimed to meet and engage local service users in considering the
acceptability of the proposed protocol, and to encourage their participation in future
and ongoing patient and public involvement activities. Four discussion groups were
held in the community with mothers of young children within the proposed trial
region, using an inclusive approach that incorporated a modified version of the
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Nominal Group Technique (NGT). Bringing the consultation to the community
supported the involvement of often seldom-heard participants, such as those from
minority ethnic groups.
Results The women involved expressed a number of concerns about the proposed
protocol, including adherence to the probiotic supplement regimen and randomisation.
The proposal for the RCT in itself was perceived as confirmation that probiotic
supplements had potentially beneficial effects, but also that they had potentially harmful
side-effects. The complexity of the women’s responses provided greater insights into the
challenges of even quite simple trial designs and enabled the research team to take
these concerns into account while planning the pilot trial.
Conclusions The use of the NGT method allowed for a consultation of a population
traditionally less likely to participate in medical research. A carefully facilitated PPI
exercise can allow members to express unanticipated concerns that may not have been
elicited by a survey method. Findings from such exercises can be utilised to improve
clinical trial design, provide insight into the feasibility of trials, and enable engagement
of often excluded population groups.
Keywords: Clinical trial acceptability, Feasibility studies, Patient and public involvement,
Advisory groups, Public understanding of clinical trials, Women’s health
Background
There is growing interest in using PPI in clinical trials, from priority setting [1, 2] through
to involvement with study design and conduct [3]. Priority-setting ensures that research is
responsive to patients’ concerns [4]; and involvement with study design means that poten-
tial challenges for individual research projects can be identified and addressed at an early
stage [5]. INVOLVE defines public involvement in research as ‘research being carried out
‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them. This includes, for
example, working with research funders to prioritise research, offering advice as members
of a project steering group, commenting on and developing research materials and under-
taking interviews with research participants’ [6]. This article describes a public consult-
ation exercise, used as a first step towards influencing the design of a clinical trial, and
with the aim to establish continued involvement throughout the trial.
To understand research needs and challenges, PPI has to engage people who are able to
offer valid perspectives from the study population. Widening inclusion has sound scien-
tific value [4]. Population groups might have different perspectives informed by, for ex-
ample, socio-economic status, ethnicity, health status, or gender, which might impact on
participants’ recruitment and retention rates in clinical trials [4, 7, 8]. PPI can help to
identify possible problems with recruitment and retention at an early stage, by developing
a better understanding of any barriers that might exist [9–12]. Being inclusive of people
from diverse backgrounds in consultation work is also a matter of health equity. Barriers
to participation that go beyond the more often cited structural barriers within healthcare
(such as time and staffing), or individual choice (such as preferences for certain treat-
ments, or concerns about efficacy of a new treatment), may be highlighted [7, 8]. Despite
positive changes in policy and practice that no longer automatically exclude people from
ethnic minorities in medical research, people from minority ethnic groups may be system-
atically excluded from participation in clinical trials due to a number of indirect factors,
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such as mistrust, inappropriate exclusion criteria, access difficulties, interpretation and
translation costs, socio-cultural barriers, and cultural myths [13, 14].
Early PPI in the development of a trial can yield valuable findings [8, 9], but consulta-
tions often occur later in the development process, such as during a pilot trial. Boote et
al’s review of PPI in trials identified that even in trials with involvement at the design stage
this was mainly in designing materials and leaflets for patients and agreeing outcome mea-
sures and tools, or in monitoring the process, rather than at an earlier stage of the design
[4]. In contrast, Edwards et al’s study showed that by involving families early in the design
of a trial for children with cerebral palsy, the research team was able to identify basic de-
sign approaches and wider outcome measures that could help improve the acceptability
and take-up of the planned trial [5]. This study was, however, based on interviews with
parents involved in an active user group and such approaches could themselves be limited
in addressing issues relevant to a diverse population.
Building on current knowledge about the benefits of PPI, the project reported here
aimed to actively involve mothers of young children in considering the feasibility and de-
sign of a proposed RCT: “PrePro - Preventing preterm birth with probiotics”. The
intended study population has a higher than national average rate of preterm birth and
marked diversity of socio-economic status and ethnicity [15]. The target population is
often considered as “hard to reach”, both in terms of geographical location and in terms
of being engaged with research. We acknowledged the benefits of carrying out such con-
sultations in the community, to avoid difficulties with travel to a central location [16]. The
proposed full-scale trial is a multicentre, placebo-controlled, double-blind RCT examining
the effects of daily probiotics from early pregnancy until the end of gestation on the
vaginal microbiological flora and risk of preterm birth [17–19]. To determine a clinically
significant effect, if any, on the risk of preterm birth, it is anticipated that 10,000 partici-
pants may be required in the RCT. Therefore, a pilot trial on 366 participants is currently
underway in order to assess acceptability and feasibility prior to conducting the full-scale
trial. In preparation for the pilot trial, we considered it important to consult with repre-
sentative service users in order to get any insights on the trial design.
The objectives of this PPI project were:
 to convene four discussion groups involving mothers of young children within the
intended trial region. i.e. East London;
 to ensure inclusion and involvement of women across the diverse community;
 to actively involve women in discussion about the trial design and seek routes for
ongoing engagement;
 to learn about the potential barriers and facilitators to carrying out the trial; and
 to consider the acceptability of the intervention: one probiotic or placebo capsule
per day from recruitment to the end of pregnancy and three self-administered
vaginal swabs at routine antenatal appointments.
Methods
PPI representatives and settings
Four mothers’ group discussions were held. Three were with mothers of babies under 1
year of age, between July and September 2013. The mothers were contacted through
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Children’s Centres in three boroughs of East London (Hackney, Waltham Forest and
Newham). As women from some minority ethnic communities (particularly those of
West African origin) are disproportionately affected by preterm birth in the UK, and
are also less likely than White British women to participate in clinical research [8, 15],
we specifically sought involvement of West African women through a church in the
borough of Tower Hamlets, where the fourth discussion group was held. The group of
women taking part were acting as advisors to the researchers and had no direct contact
with research participants, therefore ethical approval from the National Research Ethics
Service was not required, as outlined in the guidelines from INVOLVE and the
National Patient Safety Agency [6, 20]. Taking part in the discussions was voluntary
and all discussion group members gave informed consent for their contributions to be
recorded in the written notes.
A total of 35 women took part in the group discussions. One group included a female
practising midwife and a male GP, who were members of the Church group and interested
in the topic. The 35 women were aged between 27 and 43 years old, and were from a var-
iety of ethnic backgrounds including: White British (n = 5), White Other (n = 3), Indian
(n = 1), Pakistani (n = 4), East African (n = 1), West African (n = 18) and Black Caribbean
(n = 3). Whilst we were unable to be fully representative of the local population due to the
small numbers of women who took part, the distribution is reflective of the local
communities in Tower Hamlets, Waltham Forest and Newham, which have 69, 48
and 83% of their population respectively from Black and Minority Ethnic groups. We
did not collect any indicators of socio-economic status, such as income or educational
level, but the Local Authorities in which this research took place are all within the
top 40 most deprived in England.1
As with all aspects of research, engaging diverse groups of people can at times be
challenging and individuals’ willingness to engage with PPI may mirror their willing-
ness, or otherwise, to engage with clinical research, health services or state institutions.
A number of key strategies were deployed in order to minimise the barriers to attend-
ing the discussion groups. The three Children’s Centre groups existed previously to the
project and the project team ensured that the discussions were planned in a time and
place when the women were already meeting. Our previous experience of engaging
women from communities across Britain [1, 21, 22] had shown that it was often
impractical to ask women with small babies to attend an extra group meeting at a par-
ticular time of day. In contrast, visiting existing baby drop-in groups was significantly
more successful as women were used to attending these groups at regular intervals and
were also in a setting where they felt comfortable.
The Nominal Group Technique – standard and modified
The four groups were facilitated using a modified version of principles drawn from
Nominal Group Technique (NGT), which allows collective ‘brainstorming’ and group
decision-making [23, 24]. The principles were used to provide an initial structure for
the meetings, but were applied in a very flexible fashion in response to the group on
the day. The aim of NGT is to give individuals an equal opportunity to contribute to
collective decision-making and to attempt to mitigate against group dynamics based on
personality and the social dynamics of power. When using NGT, the facilitator allows
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everyone in the group time alone to consider and record as many responses as possible
to a question. The responses are then collected by the facilitator and shared with the
group or read out by group members. No criticism, comment or judgement is made on
the responses by the facilitator, but they may offer clarification or responses to specific
questions. The group then engages in an open and detailed facilitated discussion of the
issues raised. Finally, group members vote on which responses they feel are important
or useful, often using a ranking approach.
We knew from previous research with the Bangladeshi community in East London
that women in that community preferred to engage with healthcare professionals
through face-to-face discussions rather than written materials [21] and this kind of
community intelligence was crucial to guiding our approach for this project. In
addition, group discussions allow the conversation to flow, without a specific agenda.
Whilst we had pre-existing ideas about what some barriers or facilitators to trial par-
ticipation might be, these did not set the topic of the conversations. Convening group
discussions like this better supported service users to engage with the design of the trial
and understand what was being asked of them. Due to the nature of this method, we
did not know who would be attending the groups in advance. This meant we could not
plan interpretation for women who may have come and who spoke no English. How-
ever, with slow and careful facilitation and small group working, women with limited
spoken or written English were supported to participate by their peers. Some informal
interpretation between participants was common during the sessions, and volunteer
‘scribes’ within pairs or small groups ensured that everyone’s ideas were included in the
written activity.
Whilst the discussions used a number of tools from NGT, our strategy differed in a
number of ways from the standard NGT model. An A1-sized flow chart representing
the planned trial protocol was used to help explain the recruitment, randomisation and
intervention involved in the trial, in a visual manner. The proposed protocol was ex-
plained verbally to each group by the researcher. Each group was asked to imagine that
they were being invited to join the trial at their routine antenatal dating scan appoint-
ment and consider, hypothetically, what questions or concerns they might have about
participating. Each group was told that this information would be used to make adjust-
ments to the procedures for the trial or the information given to future trial partici-
pants, to help ensure that the trial is as ‘user-friendly’ as possible for those who are
asked to participate. We gave reassurance that contributing to the PPI exercise did not
mean that the women present were being asked to participate in the trial, nor would
they necessarily be in the future. However, we did seek each participant’s interest in
continuing their involvement as a PPI representative.
The women’s concerns and questions were written onto individual sticky notes by
the women in the group or by the researcher and placed onto the flowchart at the point
in the process to which they referred. We did not attempt to actively answer or address
women’s concerns and questions during the activity; these were simply recorded, but
some additional clarification of the trial protocol was given during the discussion if
needed. We did not require the women to rank or vote on the responses as in standard
NGT; all ideas were considered of equal value to developing the protocol. By working
with the discussion group to address the protocol step-by-step, the women in the
groups contributed to the analysis of their own contributions. The women sorted the
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concerns and questions according to which part of the protocol they addressed (e.g.
recruitment, randomisation, vaginal swab, probiotic capsule regimen, qualitative inter-
views). Following the discussion groups, all queries were collected and transcribed for
future reference.
Additional PPI activity
Complementary to the NGT session, during the pilot trial we involved the women’s
health research advisory group “Katie’s Team”, which is based in East London and is
made up of patient and public representatives. The women who participate in Katie’s
Team reflect the ethnic make-up of the area, being 60% of South Asian origin, 5% of
West African origin and 35% of a number of other ethnicities [25]. This advisory group
consults on numerous research projects and clinical trials within women’s health, and
so their involvement with PrePro brings great value to our discussions on trial design,
feasibility and progress.
Women who were interested in being involved in the ongoing development of the trial
were asked to provide their contact details. These women (n = 9) were later re-contacted
during the pilot trial and invited to contribute further to the project’s development. These
contributions included being invited to join Katie’s Team and to volunteer as PPI repre-
sentatives on the trial steering group.
Results
A key aim of the public consultation exercise was to assess the acceptability of the
protocol of a daily probiotic capsule and three self-collected vaginal swabs. Whilst a
quantitative research approach using a questionnaire would have enabled us to evaluate
the views of a larger number of women in the trial region, there were a number of con-
cerns with using questionnaires. Firstly, they rely on good levels of literacy in English,
which could not be guaranteed in the target geographical region. Secondly, they rely on
volunteers completing them and returning them by post, or online, which has been
linked to a very poor response rate amongst more deprived populations [21]. Thirdly,
the development of a survey requires some initial hypotheses or assumptions about the
problems women may find during the trial, thereby restricting the possible findings
within the boundaries of those hypotheses.
We were able to involve a diverse sample of women by making contact with existing
community-based groups: women attending Children’s Centre baby drop-in groups and
members of a local church, rather than requiring women to attend a focus group in an
unfamiliar venue. Children’s Centres have traditionally provided services for women in
lower socio-economic groups. Whilst their catchment has diversified in recent years,
many are still used by a more socially disadvantaged and diverse sector of the popula-
tion. Although Children’s Centre groups do not necessarily include women who are sig-
nificantly socially isolated, we could consult women whose voices are seldom-heard in
PPI. The church group was contacted specifically to ensure that we involved women of
West African origin, as they are disproportionately affected by preterm birth. The flexi-
bility of the approach allowed women to bring up any concerns or questions they had.
Furthermore, discussions developed from each individual’s initial suggestions, which
meant that others were encouraged to think differently about their own potential
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participation, and to agree or to refute others’ suggestions. The women became more
actively engaged in the process of thinking about and planning the trial.
Adherence and randomisation
One of the biggest findings was that many women were concerned about the practical-
ities of taking part in the trial and did not have confidence that they would remember
to take the capsules in accordance with the protocol, as pregnancy was already a de-
manding time in their lives. Women were also often concerned about being rando-
mised, particularly to the placebo arm of the trial. This concern could be expected, but
it introduces a particular threat to the success of this trial, which would test products
that are freely available to participants over the counter. Rather than participating in
the trial to gain access to otherwise unavailable medications, which may be the case in
many drug trials, the women taking part in this exercise were more concerned that par-
ticipating in this trial could deny their access to potentially beneficial, widely available,
probiotic supplements. Some participants suggested that the possibility of receiving a
placebo after consenting to participate might encourage them to take ‘over the counter’
probiotics to supplement the trial.
Women’s perceptions
The most novel insight emerging from these discussions was in relation to women’s
perceptions of the safety of the probiotics themselves. It appeared that the process of
explaining a trial to potential participants may heighten awareness of both the potential
benefits and the potential risks of an intervention. All the women had heard of probio-
tics or ‘friendly bacteria’, however, many women were hesitant about taking probiotic
capsules during pregnancy as part of a clinical trial. A large number of women felt that
it was confusing to be asked to take tablets in a trial when they were otherwise discour-
aged from taking tablets during pregnancy. One woman was concerned that bacteria
were ‘live’ and could therefore be damaging. Many women believed that all tablets had
some side effects and were worried about the ‘inevitable’ side effects of taking probiotic
capsules. Although some women said they had used or continued to use probiotics as a
dietary supplement, they still expressed concern about their safety within the context of
the trial and in a ‘tablet’ form. Interestingly, the exact same concerns of taking a tablet
being perceived as ‘medicine’, and therefore potentially harmful, were also expressed
during consultation with members from ‘Katie’s Team’.
Discussion
This approach to facilitating discussion around the trial was found to be effective in
meeting our PPI objectives, particularly in terms of involving a more diverse range of
women in the community in discussing and commenting on the plans and it provided
useful information to inform the pilot trial design and planning. Women raised con-
cerns and questions that were consistent across each of the four groups, highlighting
issues that we had anticipated and some that we had not.
Whilst both concerns regarding adherence to the protocol and randomisation could
be easily anticipated, the group discussions brought up some further findings that were
less readily expected. Although we had expected women to be more concerned by the
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more invasive part of the participation requirements, taking three self-administered
swabs was far less of a concern to women than taking daily capsules. Vaginal swabs
were perceived as common in pregnancy and all but two of the group members said
they would be happy to carry out a vaginal swab on themselves. Additionally, timing
the swabs to coincide with antenatal appointments would minimise demands on partic-
ipants. One of the two women who was not willing to carry out self-administered swabs
had been advised by her GP not to have unnecessary swabs during pregnancy and was
worried about their safety. The other woman was more comfortable with a health pro-
fessional taking a swab than it being self-administered.
Many women’s perception of the probiotic was transformed from ‘dietary supple-
ment’ to ‘drug’ by the proposed clinical trial itself. It is possible that probiotics adminis-
tered in any form other than a capsule (for example, a change in diet or a probiotic
drink) may have been more acceptable to potential participants. The existence of the
trial was seen as confirmation that probiotics had potentially beneficial effects on pre-
term birth, but also that they had potentially harmful side-effects. The women appeared
to simultaneously hold two, conflicting positions: a desire for the benefits of the probio-
tics and concern that they were unsafe. The ability of humans to maintain and act on
such complex, apparently contradictory views may be underestimated by researchers,
who often draw on a more linear and rationalistic model of human decision-making.
Conclusions
The approach described here was effective in reaching and engaging women from diverse
backgrounds, enabling involvement of a range of women who might be approached for
participation in a pregnancy-related trial. The collaborative group discussions enabled an
open, exploratory approach, which did not confine the findings to researchers’ existing
hypotheses, but instead enabled fresh issues to emerge from the women’s perspectives. It
gave us greater insight into the considerations to be addressed in designing and imple-
menting a trial on this topic and in this typically ethnically diverse and socially deprived
region. This type of involvement can complement some of the more conventional PPI
strategies, such as inviting individual PPI representatives to research team meetings or
steering committees, where the discussion is tailored towards and paced for the needs of
the researchers, rather than the service users. Going to where community members are
rather than expecting participants to come to where the researchers are is a simple but
under-utilised approach to engaging seldom-heard groups. This accessible approach also
engaged the women’s interest and enthusiasm for research, reflected in the number of
women (n = 9) from a range of ethnic backgrounds who volunteered to be contacted and
maintain an ongoing involvement as user representatives. The group discussions enabled
the research team to identify clear lessons to inform the design of a pilot trial, which is on-
going. The pilot trial has included a qualitative evaluation of the process of recruitment,
which is further exploring the ideas generated by this consultation exercise and testing
their impact on ‘real life’ trial recruitment. In combination with the public consultation
through Katie’s Team, the findings from this evaluation informed the development of the
pilot trial protocol, and will continue to inform the development of the future definitive
trial. Trial researchers facing similar challenges could also consider some of changes that
we made in response to this exercise:
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– We ensured that the information presented to participants at recruitment clearly
explained the concept of randomisation; the nature of the specific probiotic
supplements and the fact that they are not available over the counter; and their
potential effects during pregnancy.
– When in discussion with participants, we consistently described the probiotic in
terms of a ‘food supplement’ rather than a ‘medicine’.
– As there were no concerns with collecting vaginal swab samples, we ensured the
protocol allowed samples to be self-collected as well as by a healthcare professional.
– Each sample collection was timed with the regular antenatal appointments, to
enable participants to remain compliant.
– For the definitive trial, we may consider providing the probiotic supplement in
another format other than a capsule: as a drink or a powder for example.
Continued involvement of PPI representatives, as described in this study, will be an
invaluable component in considering the feasibility of progressing to a large-scale trial
and could provide a route towards engagement of a more diverse range of people in
such PPI roles. However, research teams need to be mindful that not all members of
the public will feel able (for practical reasons such as time) or confident to take on a
formal PPI representative role. Therefore, ongoing encouragement and support for par-
ticipation and consideration of how PPI representatives can be involved in groups such
as Katie’s Team and in trial steering groups also requires detailed attention.
Endnotes
1The three boroughs are ranked 11th, 24th and 36th most deprived by average Index
of Multiple Deprivation score (2015). Data available from the Office of National Statis-
tics at: https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015.
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